Начало › Рак на простатата › Пенсилвания › Philadelphia
Клинични проучвания за Рак на простатата в Philadelphia, PA
44 проучвания за Рак на простатата търсят участници в обекти в и около Philadelphia (в радиус от около 30 мили). Отворете проучването, за да видите кой може да участва и как да се свържете с екипа.
Официален текст на проучването (английски)
Търсите участници за проучване? Представяме го в началото на тази страница — $99 за 30 дни →
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Набиране на участнициФаза 1/2
- Abramson Cancer Center of the University of Pennsylvania, Philadelphia
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
Набиране на участнициФаза 3
- Thomas Jefferson University Hospital, Philadelphia
- Jefferson Torresdale Hospital, Philadelphia
- Asplundh Cancer Pavilion, Willow Grove · на 13 мили
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Набиране на участнициНаблюдателно проучванеЗдравите доброволци са добре дошли
- Reading Hospital McGlinn Cancer Institute at Phoenixville, Phoenixville · на 22 мили
A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer
Набиране на участнициФаза 1
- Sidney Kimmel Cancer Center - Jefferson Health, Philadelphia
DESTINY-PANTUMOUR04
Набиране на участнициНаблюдателно проучване
- Research Site, Philadelphia
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
Набиране на участнициФаза 3
- Fox Chase Cancer Center ( Site 0076), Philadelphia
- MidLantic urology ( Site 0022), Bala-Cynwyd · на 5 мили
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
Набиране на участнициФаза 3
- MidLantic urology, Bala-Cynwyd · на 5 мили
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
Набиране на участнициФаза 2/3
- Fox Chase Cancer Center, Philadelphia
Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
Набиране на участнициФаза 2
- Philadelphia MultiService Center, Philadelphia, PA, Philadelphia
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
Набиране на участнициФаза 3
- Perelman Center for Advanced Medicine ( Site 0067), Philadelphia
- Abramson Cancer Center - Penn Medicine ( Site 0079), Philadelphia
First-Time-in-Human Study of GSK5471713 in Adults With mCRPC
Набиране на участнициФаза 1/2
- GSK Investigational Site, Philadelphia
Trial of Xaluritamig in Adults With Metastatic Castration-resistant Prostate Cancer
Набиране на участнициФаза 1
- Thomas Jefferson University, Philadelphia
Sacral Neuromodulation for Male Overactive Bladder (MOAB)
Набиране на участници
- MidLantic Urology, Bala-Cynwyd · на 5 мили
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Набиране на участнициФаза 3
- Christiana Care Health System-Concord Health Center, Chadds Ford · на 23 мили
- Christiana Care Health System-Wilmington Hospital, Wilmington · на 25 мили
A Study of Tarlatamab for People With Prostate Cancer
Набиране на участнициФаза 2
- Thomas Jefferson University Hospital, Philadelphia
Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
Набиране на участнициФаза 1
- Thomas Jefferson University, Philadelphia
A Study of Talazoparib With or Without Enzalutamide in People With Prostate Cancer Who Have Previously Received Abiraterone Acetate or Darolutamide
Набиране на участнициФаза 2
- Abramson Cancer Center of the University of Pennsylvania, Hospital of the University of Pennsylvania, Philadelphia
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
Набиране на участнициФаза 3
- Penn Presbyterian Medical Center, Philadelphia
- University of Pennsylvania/Abramson Cancer Center, Philadelphia
- Thomas Jefferson University Hospital, Philadelphia
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Набиране на участнициФаза 1/2
- University of Pennsylvania, Perelman School of Medicine, Philadelphia
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
Набиране на участнициФаза 1
- Thomas Jefferson University Honickman Center, Philadelphia
Evaluation of Neoadjuvant Xaluritamig in Localized Prostate Cancer
Набиране на участнициФаза 1
- Thomas Jefferson University, Philadelphia
PSMA PET Combined With MRI for the Detection of PCa
Набиране на участнициФаза 3Здравите доброволци са добре дошли
- MidLantic Urology, Philadelphia
Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors
Набиране на участнициФаза 1
- Investigative Site #109, Philadelphia
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
Набиране на участнициФаза 3
- Philadelphia Veterans Administration Medical Center, Philadelphia
- Christiana Care Health System-Concord Health Center, Chadds Ford · на 23 мили
- Christiana Care Health System-Wilmington Hospital, Wilmington · на 25 мили
Study of ORIC-944 in Patients With Metastatic Prostate Cancer
Набиране на участнициФаза 1
- MidLantic Urology, Bala-Cynwyd · на 5 мили
Study Evaluating the Safety, Tolerability, and Efficacy of Xaluritamig in Combination With Androgen Receptor Pathway Inhibitors in Participants With Metastatic Hormone-sensitive Prostate Cancer
Набиране на участнициФаза 1
- Thomas Jefferson University, Philadelphia
A Study of Tinengotinib (TT-00420) in Combination With Standard Treatments in People With Prostate Cancer
Набиране на участнициФаза 1/2
- Thomas Jefferson University Hospital, Philadelphia
Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.
Набиране на участнициФаза 2
- Corporal Michael J. Crescenz VA Medical Center, Philadelphia
TERPS Trial for de Novo Oligometastic Prostate Cancer
Набиране на участнициФаза 2
- Sidney Kimmel Cancer Center at Jefferson Health, Philadelphia
International Registry for Men With Advanced Prostate Cancer (IRONMAN)
Набиране на участнициНаблюдателно проучване
- Fox Chase Cancer Center - Temple Health, Philadelphia
Prostate Cancer Screening for People at Genetic Risk for Aggressive Disease, PATROL Study
Набиране на участнициНаблюдателно проучванеЗдравите доброволци са добре дошли
- University of Pennsylvania/Abramson Cancer Center, Philadelphia
Extending Prostate Genetic Awareness, Navigation, and Delivery: The EXPAND Network
Набиране на участнициНаблюдателно проучванеЗдравите доброволци са добре дошли
- Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia
Peer Navigation for the Support of Metastatic Prostate Cancer Patients Undergoing Genetic Evaluation
Набиране на участници
- Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University, Philadelphia
Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer
Набиране на участнициФаза 2/3
- Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA, Philadelphia
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
Набиране на участнициФаза 1/2
- Thomas Jefferson University, Sidney Kimmel Comprehensive Cancer Center, Philadelphia
Study of AZD0754 in Participants With Metastatic Prostate Cancer
Набиране на участнициФаза 1/2
- Research Site, Philadelphia
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
Набиране на участнициФаза 1
- Thomas Jefferson University, Sidney Kimmel Cancer Center, Philadelphia
- Fox Chase Cancer Center, Philadelphia
Hypofractionated WPPT With HDR Boost
Набиране на участнициФаза 2
- University of Pennsylvania, Philadelphia
A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer
Набиране на участнициФаза 1
- MidLantic Urology, Bala-Cynwyd · на 5 мили
Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years
Набиране на участнициФаза 4
- Albert Einstein Healthcare Network, Philadelphia
Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body
Набиране на участнициФаза 3
- Christiana Care Health System-Concord Health Center, Chadds Ford · на 23 мили
- Christiana Care Health System-Wilmington Hospital, Wilmington · на 25 мили
Prostate Tissue BioBank
Набиране на участнициНаблюдателно проучване
- University of Pennsylvania, Philadelphia
Adaptive Radiation Therapy for Men With Intermediate- or High-Risk Prostate Cancer
Набиране на участници
- Fox Chase Cancer Center, Philadelphia
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Набиране на участнициНаблюдателно проучване
- Massive Bio SYNERGY-AI site, Philadelphia
Проучвания за Рак на простатата в други градове
- New York City, NY103 проучвания
- Houston, TX76 проучвания
- Los Angeles, CA61 проучвания
- Boston, MA59 проучвания
- St. Louis, MO46 проучвания
- Chicago, IL45 проучвания
- San Francisco, CA45 проучвания
- Baltimore, MD43 проучвания
- Nashville, TN43 проучвания
- Seattle, WA42 проучвания
- Washington, DC38 проучвания
- Dallas, TX36 проучвания
Други проучвания в Philadelphia
- Рак (всички видове)59 проучвания
- Рак на гърдата56 проучвания
- Рак на белия дроб с недребноклетъчен тип51 проучвания
- Метастатичен рак46 проучвания
- Колоректален рак44 проучвания
- Рак на яйчниците44 проучвания
- Рак на белия дроб36 проучвания
- Остра миелоидна левкемия34 проучвания
- Сърдечна недостатъчност31 проучвания
- Ендометриален рак28 проучвания
- Депресия26 проучвания
- Рак на панкреаса26 проучвания
От ClinicalTrials.gov, данни към 6.10.2026 г.. Всяко проучване има свои критерии за участие; екипът на проучването определя кой може да се включи.